诊断前糖蛋白乙酰基水平与痛风初发及复发风险:基于人群的前瞻性研究及孟德尔随机化分析(校正血清尿酸水平)
在105,615名英国生物银行无痛风史参与者中,诊断前代谢组学分析显示,校正血清尿酸后仅糖蛋白乙酰基(GlycA)与痛风初发相关(极端五分位HR 1.52,95%CI 1.22-1.88),且随空腹时间延长关联增强;GlycA亦与复发 flares 相关(RR 1.90,95%CI 1.27-2.85);孟德尔随机化支持GlycA对痛风风险的潜在因果作用。
要点
- 校正血清尿酸后,仅GlycA与痛风初发独立相关,极端五分位HR 1.52(95%CI 1.22-1.88)。
- 空腹≥8小时者GlycA与痛风初发关联更强,HR 4.01(95%CI 1.36-11.82)。
- GlycA与复发痛风 flares 相关,极端五分位RR 1.90(95%CI 1.27-2.85)。
核心结论
- 这项前瞻性人群研究提示,GlycA这一反映中性粒细胞过度活性的稳定长期生物标志物,在血清尿酸之外与痛风初发及复发 flares 相关;孟德尔随机化支持GlycA对痛风风险的潜在因果作用。
研究设计与样本
- 在105,615名无痛风史的英国生物银行参与者中,利用2006-2010年基线血样的核磁共振代谢组学数据(168种代谢物)进行诊断前全代谢组分析;计算痛风初发的HR,校正痛风危险因素,分别排除和纳入血清尿酸,总体及按采样前空腹时间分析;用两样本孟德尔随机化检验潜在因果效应;用泊松回归计算初发痛风病例中与复发 flares 关联的RR。
主要发现
- 校正多重检验后,血清尿酸校正前有88种代谢物与痛风初发风险相关(N=1,303例),包括谷氨酰胺和甘氨酸(负相关)、脂质、支链氨基酸,以及最突出的GlycA(P=9.17×10⁻³²)。
- 血清尿酸校正后,仅GlycA仍与痛风初发相关(极端五分位HR 1.52,95%CI 1.22-1.88);该HR随采样前空腹时间延长而递增,空腹≥8小时达4.01(95%CI 1.36-11.82)。
- GlycA每标准差变化的相应HR总体为1.10(95%CI 1.04-1.17),空腹≥8小时为1.54(95%CI 1.21-1.96)。
- 初发痛风病例中,GlycA水平亦与复发痛风 flares 相关(极端五分位RR 1.90,95%CI 1.27-2.85),空腹时关联更大。
- 孟德尔随机化证实GlycA对痛风风险具有潜在因果作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To prospectively investigate population-based metabolomics for incident gout and reproduce the findings for recurrent flares, accounting for serum urate. METHODS: We conducted a prediagnostic metabolome-wide analysis among 105,615 UK Biobank participants with nuclear magnetic resonance metabolomic profiling data (168 total metabolites) from baseline blood samples collected 2006-2010 in those without history of gout. We calculated hazard ratios (HRs) for incident gout, adjusted for gout risk factors, excluding and including serum urate levels, overall and according to fasting duration before sample collection. Potential causal effects were tested with 2-sample Mendelian randomization. Poisson regression was used to calculate rate ratios (RRs) for the association with recurrent flares among incident gout cases. RESULTS: Correcting for multiple testing, 88 metabolites were associated with risk of incident gout (N = 1,303 cases) before serum urate adjustment, including glutamine and glycine (inversely), and lipids, branched-chain amino acids, and most prominently, glycoprotein acetyls (GlycA; P = 9.17 × 10-32 ). Only GlycA remained associated with incident gout following urate adjustment (HR 1.52 [95% confidence interval (95% CI) 1.22-1.88] between extreme quintiles); the HR increased progressively with fasting duration before sample collection, reaching 4.01 (95% CI 1.36-11.82) for ≥8 hours of fasting. Corresponding HRs per SD change in GlycA levels were 1.10 (95% CI 1.04-1.17) overall and 1.54 (95% CI 1.21-1.96) for ≥8 hours of fasting. GlycA levels were also associated with recurrent gout flares among incident gout cases (RR 1.90 [95% CI 1.27-2.85] between extreme quintiles) with larger associations with fasting. Mendelian randomization corroborated a potential causal role for GlycA on gout risk. CONCLUSION: This prospective, population-based study implicates GlycA, a stable long-term biomarker reflecting neutrophil overactivity, in incident and recurrent gout flares (central manifestation from neutrophilic synovitis) beyond serum urate.
引用
- Joshi AD, McCormick N, Yokose C, et al. Prediagnostic Glycoprotein Acetyl Levels and Incident and Recurrent Flare Risk Accounting for Serum Urate Levels: A Population-Based, Prospective Study and Mendelian Randomization Analysis. Arthritis Rheumatol. 2023. PMID: 37043280. doi:10.1002/art.42523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。